![Ian Nicholson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Nicholson
Président chez
BIOVENTIX PLC
Fortune : 327 383 $ au 31/05/2026
Profil
Ian James Nicholson is currently Non-Executive Chairman at Bioventix Plc since 2004.
Director at Casewell Consulting Ltd., Wells Stores Ltd., and Lifearc (Trustee).
Non-Executive Director at BenevolentAI SA since 2024.
Operating Partner at Advent Venture Partners LLP and Advent Life Sciences LLP since 2012.
Former Chief Executive Officer at Chroma Therapeutics Ltd. from 2004 to 2012.
Chief Executive Officer & Director at F2G Ltd. from 2013 to 2021.
Director at Consort Medical Ltd. from 2012 to 2020.
Independent Non-Executive Director at Clinigen Ltd. from 2012 to 2021.
Senior Vice President-Business Development at Celltech Group Plc from 2000 to 2004.
Director at Servier Symphogen A, The Bioindustry Association, and Macrotarg Ltd. Principal at Lonza Group AG, Oxford Asymmetry International Plc, and GE Healthcare Ltd. (United Kingdom).
Education includes an MBA from Boston University in 1992 and an undergraduate degree from University College London in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOVENTIX PLC 0,28% | 10/04/2026 | 14 500 ( 0,28% ) | 327 383 $ | 31/05/2026 |
Postes actifs de Ian Nicholson
| Sociétés | Poste | Début |
|---|---|---|
| BIOVENTIX PLC | Président | 01/11/2004 |
| BENEVOLENTAI S.A. | Directeur/Membre du Conseil | 02/05/2024 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/01/2012 |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Operates as a life science medical research charity company | Directeur/Membre du Conseil | - |
Wells Stores Ltd. | Directeur/Membre du Conseil | - |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Corporate Officer/Principal | 01/01/2012 |
Casewell Consulting Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ian Nicholson
| Sociétés | Poste | Fin |
|---|---|---|
| CLINIGEN GROUP PLC | Directeur/Membre du Conseil | 24/11/2021 |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Directeur Général | 12/04/2021 |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Ian Nicholson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Consort Medical Ltd.
 Consort Medical Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Lonza Group AG
 Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Bioventix Plc
 Bioventix Plc BiotechnologyHealth Technology Develops and manufactures sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Operates as a life science medical research charity company | Commercial Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Macrotarg Ltd.
 Macrotarg Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical services company that engages in clinical trails, regulatory affairs, distribution and commercialization of pharma companies | Commercial Services |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Health Technology |
Casewell Consulting Ltd. | |
Wells Stores Ltd. | |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
